Structure–Activity Relationship Studies of DNA Methyltransferase 1 Monovalent Degraders
- 5 February 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (3) , 2903-2919
Abstract
DNA methyltransferase 1 (DNMT1), which catalyzes maintenance methylation of hemimethylated DNA during DNA replication, is overexpressed in cancer. Recently, the first-in-class DNMT1-selective noncovalent small-molecule inhibitors, GSK3484862 and GSK3685032, were discovered. These inhibitors were also reported to degrade DNMT1. However, structure-activity relationship (SAR) studies of these monovalent DNMT1 degraders are lacking. Here, we report our SAR studies of this scaffold on degrading DNMT1, which led to the discovery of multiple lead degraders, including compound 4 (MS9024). Compound 4 potently and selectively degraded DNMT1 in multiple cancer cell lines in a concentration-, time-, and proteasome-dependent manner without altering DNMT1 transcription. Further mechanism-of-action studies suggest that the DNMT1 degradation induced by 4 was not mediated by lysosome or cullin RING E3 ligases but could potentially be mediated by HECT E3 ligases and/or UHRF1. Collectively, these studies pave the way for further developing DNMT1 monovalent degraders as potential therapeutics and useful chemical tools.Keywords
Funding Information
- National Cancer Institute (F32CA260116, R01CA283464, R21CA277152, T32CA078207)
- NIH Office of the Director (1S10OD025132, 1S10OD028504)
- National Institute of General Medical Sciences (R35GM134744)
This publication has 46 references indexed in Scilit:
- Biochemical and structural characterization of the first-discovered metazoan DNA cytosine-N4 methyltransferase from the bdelloid rotifer Adineta vagaJournal of Biological Chemistry, 2023
- The Rise of Molecular GluesCell, 2021
- Defining a Cancer Dependency MapCell, 2017
- Design, Synthesis and Biological Evaluation of 4‐Amino‐N‐(4‐aminophenyl)benzamide Analogues of Quinoline‐Based SGI‐1027 as Inhibitors of DNA MethylationChemMedChem, 2014
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyThe Lancet Oncology, 2009
- Mammalian DNA Methyltransferases: A Structural PerspectiveStructure, 2008
- Increased DNA Methyltransferase 1 (DNMT1) Protein Expression Correlates Significantly with Poorer Tumor Differentiation and Frequent DNA Hypermethylation of Multiple CpG Islands in Gastric CancersThe American Journal of Pathology, 2004
- DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian DevelopmentCell, 1999
- Cytosine methylation and the ecology of intragenomic parasitesTrends in Genetics, 1997
- Cellular differentiation, cytidine analogs and DNA methylationCell, 1980